Liquidity Ratios

Current Ratio
Mar-03
Mar-04
Mar-05
Mar-06
Mar-07
Mar-08
Mar-09
Mar-10
Mar-11
Mar-12
Mar-13

3.66
2.69
9.89
7.85
4.82
2.85
3.55
4.59
5.97
3.90
3.37

Quick Ratio
Mar-03
Mar-04
Mar-05
Mar-06
Mar-07
Mar-08
Mar-09
Mar-10
Mar-11
Mar-12
Mar-13

2.49
1.83
9.05
6.94
4.17
2.47
3.06
3.81
5.18
3.27
2.61

Long term
solvency

Total Debt/Equity
Mar-03
Mar-04
Mar-05
Mar-06
Mar-07
Mar-08
Mar-09
Mar-10
Mar-11
Mar-12
Mar-13

0.02
0.36
1.64
1.19
0.44
0.02
0.00
0.01
0.01
0.01
0.01

Interest Cover
Mar-03
Mar-04
Mar-05
Mar-06
Mar-07
Mar-08
Mar-09
Mar-10
Mar-11
Mar-12
Mar-13

269.97
82.22
29.20
44.52
73.79
208.94

2465.37
4014.56
1507.89

Operational & Financial

ratios

Earning per Share

Mar-03
Mar-04
Mar-05
Mar-06
Mar-07
Mar-08
Mar-09
Mar-10
Mar-11
Mar-12
Mar-13

24.83
27.86
16.47
24.83
32.52
48.96
61.09
43.39
13.36
16.39
4.99

Dividend per share

Mar-03
Mar-04
Mar-05
Mar-06
Mar-07
Mar-08
Mar-09
Mar-10
Mar-11
Mar-12
Mar-13

5.00
6.50
3.75
5.50
6.75
10.50
13.75
13.75
3.50
4.25
5.00

Dividend Pay Out Ratio(%)

Mar-03
Mar-04
Mar-05
Mar-06
Mar-07
Mar-08
Mar-09
Mar-10
Mar-11
Mar-12
Mar-13

20.14
23.33
22.76
22.15
20.76
21.45
22.51
31.69
26.19
25.93
100.24

Performance Ratios

Return on Assets Ratio

Mar-03
Mar-04
Mar-05
Mar-06
Mar-07
Mar-08
Mar-09
Mar-10
Mar-11
Mar-12
Mar-13

30.34
22.51
13.12
13.51
16.24
21.13
21.55
13.96
19.32
19.96
5.50

Return on Equity(%)
Mar-03
Mar-04
Mar-05
Mar-06
Mar-07
Mar-08
Mar-09
Mar-10
Mar-11
Mar-12
Mar-13

38.06
34.02
31.38
35.93
32.16
30.47
27.04
16.54
22.32
23.32
6.59

Asset Turnover Ratio

Mar-03
Mar-04
Mar-05
Mar-06
Mar-07
Mar-08
Mar-09
Mar-10
Mar-11
Mar-12
Mar-13

1.04
0.86
0.54
0.51
0.59
0.67
0.67
0.39
0.44
0.48
0.27

Inventory Turnover Ratio

Mar-03
Mar-04
Mar-05
Mar-06
Mar-07
Mar-08
Mar-09
Mar-10
Mar-11
Mar-12
Mar-13

5.55
6.27
7.20
7.74
7.72
8.88
8.96
4.79
5.32
6.49
3.34

Debtors Turnover Ratio

Mar-03
Mar-04
Mar-05
Mar-06
Mar-07
Mar-08
Mar-09
Mar-10
Mar-11
Mar-12
Mar-13

5.22
6.10
6.89
7.09
5.61
3.96
4.52
4.10
5.77
6.50
3.47

Fixed Asset Turnover

Mar-03
Mar-04
Mar-05
Mar-06
Mar-07
Mar-08
Mar-09
Mar-10
Mar-11
Mar-12
Mar-13

2.48
2.34
2.23
2.57
2.91
3.62
3.93
2.28
2.60
2.97
1.57

Profitability
Ratios
Profitability ratios

Net Sales Growth

Mar-03
Mar-04
Mar-05
Mar-06
Mar-07
Mar-08
Mar-09
Mar-10
Mar-11
Mar-12
Mar-13

4.02
29.75
28.04
39.62
33.66
40.21
22.63
-35.63
25.03
29.22
-39.43

EBIT Growth(%)
Mar-03
Mar-04
Mar-05
Mar-06
Mar-07
Mar-08
Mar-09
Mar-10
Mar-11
Mar-12
Mar-13

34.80
17.28
12.54
49.25
29.89
62.82
22.53
-26.73
53.25
18.68
-61.57

PAT Growth(%)
Mar-03
Mar-04
Mar-05
Mar-06
Mar-07
Mar-08
Mar-09
Mar-10
Mar-11
Mar-12
Mar-13

37.22
12.08
17.87
50.89
36.34
61.23
-28.98
53.99
22.67
-69.57

Industry Comparison

Return on Equity

Dr Reddys Lab
Lupin
Cipla
Sun Pharma Inds.
Glaxosmithkline
Phar

17.6
29.41
18.38
6.59
29.38

ROCE%

Dr Reddys Lab

20.07

Lupin

33.96

Cipla

23.53

Sun Pharma
Inds.
Glaxosmithkline
Phar

8.42
43

PBIDT

Dr Reddys Lab

2132.6

Lupin

1907.23

Cipla

2348.27

Sun Pharma Inds.

Glaxosmithkline
Phar

749.29
1012.95

PAT

Dr Reddys Lab

1265.5

Lupin

1260.43

Cipla

1507.11

Sun Pharma
Inds.

516.55

Glaxosmithkline
Phar

577.26

DU-pont
analysis

Assets
to
PATM
Sales/TA Equity ROE (%)
Mar-03
29.08
1.04
1.25
38.06
Mar-04
26.11
0.86
1.51
34.02
Mar-05
24.41
0.54
2.39
31.38
Mar-06
26.48
0.51
2.66
35.93
Mar-07
27.31
0.59
1.98
32.16
Mar-08
31.58
0.67
1.44
30.47
Mar-09
32.23
0.67
1.25
27.04
Mar-10
35.51
0.39
1.18
16.54
Mar-11
43.79
0.44
1.16
22.32
Mar-12
41.60
0.48
1.17
23.32
Mar-13
20.51
0.27
1.20
6.59

Fund flow statement is a statement prepared

to analyse the reasons for changes in financial

position of the company between the 2
balance-sheets. It shows the inflow and
outflow of funds i.e. the inflow & outfow of
funds.